Pharmaceuticals and Biotech

Regulatory and reimbursement bottlenecks encouraging new business-models

The pharmaceutical industry is in a transformative phase with trends around value-based treatment, personalization and regulatory stringency. Evolving disease patterns towards chronic conditions in emerging markets, and aging population are other drivers for the industry. Companies are focusing more on R&D productivity, virtual clinical trials, and open innovation, while pricing pressures from biosimilars and generics remains a challenge.

Experience across the value chain

Our expertise across the product life cycle right from innovation R&D to Commercialization to life-cycle management will help you get a 360 degree view on future trends, market potential and positioning.

Experience across the value chain

Our expertise across the product life cycle right from innovation R&D to Commercialization to life-cycle management will help you get a 360 degree view on future trends, market potential and positioning.

     Select coverage areas

  • Clinical trial analytics
  • MOA and Target Identification
  • Epidemiology
  • Indication landscape
  • Technology scouting
  • Gene therapy services
  • Competitive landscape
  • Literative analysis
  • Evidence generation

Few key questions clients are asking us in the area of Pharmaceuticals and Biotech

What are the different models for value-based treatments in oncology in US?

What are the technologies available for releasing antibiotics through joint replacement implants for 4-8 weeks?

What are strategies and productivity benchmarks of US & EU-5 based small and medium size companies for “virtual clinical trials” ?

How competitors have had overcome the price barriers by applying cost sharing models in the treatment of cancer and diabetes through insulin in ‘out-of-pocket’ geographies ?

What is the market potential and the addressable patient pools for a novel drug in hemophilia A across US and Japan?

Who are the suitable partners in terms of capability, innovation, portfolio, geographic reach etc. for vaccine production?

Our Clients

Our long-standing clients include the worlds leading brands and forward-thinking corporations.

Talk to us about your key questions here to connect with our analyst for a no-obligation consultation.